Spectranetics Buys AngioScore

Colorado Springs-based Spectranetics said Tuesday that it is acquiring AngioScore, a developer of specialty balloons for the cardiovascular market, in a deal worth $230M plus additional earnout. AngioScore's venture backers include California Technology Ventures, Innomed Ventures, Linkagene LP, Pelion Ventures, Psilos Group Management, QuestMark Partners, Saints Capital and Telegraph Hill Partners. The acquisition is also an exit for Salt Lake City-based Pelion Ventures.